Intellectus Partners LLC lowered its position in SPDR S&P Biotech ETF ( NYSEARCA:XBI – Get Rating ) by 2.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,928 shares of the exchange traded fund's stock after selling 350 shares during the period. Intellectus Partners LLC's holdings in SPDR S&P Biotech ETF were worth $990,000 as of its most recent SEC filing. Other large investors have also recently added to or reduced their stakes in the company.

https://www.dailypolitical.com/2023/04/20/intellectus-partners-llc-sells-350-shares-of-spdr-sp-biotech-etf-nysearcaxbi.html

#dailypolitical